TOKYO, JP: Incubate Coalition Japan (ICJ) welcomes the Takaichi Cabinet's approval of the Basic Policy on Economic and Fiscal Management and Reform (Honebuto) and the Japan Growth Strategy. Together, these policies recognize life sciences innovation as a strategic driver of economic growth and signal Japan's intention to strengthen its position as a destination for global investment and scientific leadership. "Early-stage investors allocate capital globally, and they allocate

June 7–10, 2026 | Tokyo, Japan Incubate Coalition Japan (ICJ) returned to Tokyo in June 2026 with a delegation of U.S. venture investors at an important moment for Japan’s life sciences policy. The visit coincided with the final drafting of the Takaichi administration’s Honebuto and Growth Strategy, both of which identify pharmaceuticals as a strategic sector for Japan’s economic growth. Over the course of the visit, the delegation met with members of the National Diet, offic

May 8–9, 2025 | Tokyo, Japan Incubate Coalition Japan (ICJ) returned to Tokyo in May 2025 to advance its work strengthening Japan’s life sciences ecosystem and building deeper connections among policymakers, biotechnology leaders, and global investors. Over two days, the delegation met with senior government officials and participated in discussions with Japanese pharmaceutical companies, venture investors, biotech founders, and other stakeholders focused on the policies and

This week, Japanese Prime Minister Sanae Takaichi will visit Washington for a summit with President Trump. The meeting represents a pivotal moment for the US-Japan alliance, and for the global biopharmaceutical ecosystem that both countries depend on to drive medical innovation and protect patients. At Incubate Coalition Japan, we believe the summit is an opportunity to advance a critical but often overlooked agenda: ensuring that the policy environment in Japan supports the

November 11–14, 2025 | Tokyo, Japan Incubate Coalition Japan (ICJ) returned to Tokyo in November 2025 with a delegation of U.S.-based life sciences investors and industry leaders to continue its engagement with Japanese policymakers, investors, entrepreneurs, and other stakeholders working to strengthen Japan’s biotechnology ecosystem. Over four days, the delegation met with members of the National Diet, officials from the Ministry of Health, Labour and Welfare (MHLW) and Min